Growth Metrics

Cytosorbents (CTSO) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 66.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 66.47%
Dec 31, 2025 -106.11%
Sep 30, 2025 -4.63%
Jun 30, 2025 68.52%
Mar 31, 2025 28.24%
Dec 31, 2024 63.46%
Sep 30, 2024 52.69%
Jun 30, 2024 30.85%
Mar 31, 2024 -55.39%
Dec 31, 2023 -19.98%
Sep 30, 2023 22.70%
Jun 30, 2023 13.77%
Mar 31, 2023 61.72%
Dec 31, 2022 2.75%
Sep 30, 2022 -62.93%
Jun 30, 2022 -294.84%
Mar 31, 2022 -246.35%
Dec 31, 2021 -419.15%
Sep 30, 2021 -25.86%
Jun 30, 2021 -205.06%
Mar 31, 2021 26.96%
Dec 31, 2020 74.35%
Sep 30, 2020 36.94%
Jun 30, 2020 160.78%
Mar 31, 2020 24.26%
Dec 31, 2019 -52.35%
Sep 30, 2019 -97.60%
Jun 30, 2019 3.16%
Mar 31, 2019 -92.29%
Dec 31, 2018 -561.11%
Sep 30, 2018 -20.72%
Jun 30, 2018 -74.84%
Mar 31, 2018 -11.05%
Dec 31, 2017 62.05%
Sep 30, 2017 11.55%
Jun 30, 2017 2.03%
Mar 31, 2017 -57.36%
Dec 31, 2016 51.51%
Sep 30, 2016 -9.06%
Jun 30, 2016 26.02%
Mar 31, 2016 35.68%
Dec 31, 2015 -6.38%
Sep 30, 2015 -17.39%
Jun 30, 2015 -77.90%
Mar 31, 2015 -145.03%
Dec 31, 2014 -89.75%
Sep 30, 2014 -248.27%
Jun 30, 2014 -42.68%
Mar 31, 2014 1.16%
Dec 31, 2013 -44.71%
Sep 30, 2013 12.92%
Jun 30, 2013 10.70%
Mar 31, 2013 24.51%
Dec 31, 2012 31.30%
Sep 30, 2012 42.15%
Jun 30, 2012 -11.03%
Mar 31, 2012 -82.38%
Dec 31, 2011 -65.97%
Sep 30, 2011 -73.21%